Vaxxinity, Inc. (VAXX) Misses Q3 EPS by 989c
Tweet
Share
E-mailGet Alerts VAXX Hot Sheet
Join SI Premium – FREE
Vaxxinity, Inc. (NASDAQ: VAXX) reported Q3 EPS of ($10.00), $9.89 worse than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Vaxxinity, Inc. (VAXX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Reading (RDI) Tops Q2 EPS by 4c
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
